136 related articles for article (PubMed ID: 30471199)
1. Risk factors associated with pseudoaldosteronism in patients with chronic hepatitis: A retrospective cohort study.
Komatsu A; Yoshino T; Suzuki T; Nakamura T; Kanai T; Watanabe K
Basic Clin Pharmacol Toxicol; 2019 May; 124(5):607-614. PubMed ID: 30471199
[TBL] [Abstract][Full Text] [Related]
2. Identification of glycyrrhizin metabolites in humans and of a potential biomarker of liquorice-induced pseudoaldosteronism: a multi-centre cross-sectional study.
Takahashi K; Yoshino T; Maki Y; Ishiuchi K; Namiki T; Ogawa-Ochiai K; Minamizawa K; Makino T; Nakamura T; Mimura M; Watanabe K
Arch Toxicol; 2019 Nov; 93(11):3111-3119. PubMed ID: 31605160
[TBL] [Abstract][Full Text] [Related]
3. Exploration for the real causative agents of licorice-induced pseudoaldosteronism.
Makino T
J Nat Med; 2021 Mar; 75(2):275-283. PubMed ID: 33481180
[TBL] [Abstract][Full Text] [Related]
4. Liquorice-induced hypokalaemia in patients treated with Yokukansan preparations: identification of the risk factors in a retrospective cohort study.
Shimada S; Arai T; Tamaoka A; Homma M
BMJ Open; 2017 Jun; 7(6):e014218. PubMed ID: 28619768
[TBL] [Abstract][Full Text] [Related]
5. A semi-physiologically based pharmacokinetic pharmacodynamic model for glycyrrhizin-induced pseudoaldosteronism and prediction of the dose limit causing hypokalemia in a virtual elderly population.
Xu R; Liu X; Yang J
PLoS One; 2014; 9(12):e114049. PubMed ID: 25463381
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the exposure of glycyrrhizin and its metabolites and the pseudoaldosteronism after intravenous administration of alpha- and beta-glycyrrhizin in rat.
Xu R; Xiao Q; Cao Y; Yang J
Drug Res (Stuttg); 2013 Dec; 63(12):620-4. PubMed ID: 23864391
[TBL] [Abstract][Full Text] [Related]
7. Pseudoaldosteronism caused by combined administration of cilostazol and glycyrrhizin.
Maeda Y; Inaba N; Aoyagi M; Tanase T; Shiigai T
Intern Med; 2008; 47(14):1345-8. PubMed ID: 18628584
[TBL] [Abstract][Full Text] [Related]
8. Pseudoaldosteronism with increased serum cortisol associated with pneumonia, hypouricemia, hypocalcemia, and hypophosphatemia.
Onishi A; Muto S; Homma S; Inaba T; Shuto R; Kusano E; Asano Y
Clin Nephrol; 2010 Nov; 74(5):403-8. PubMed ID: 20979951
[TBL] [Abstract][Full Text] [Related]
9. 3-Monoglucuronyl glycyrrhretinic acid is a possible marker compound related to licorice-induced pseudoaldosteronism.
Makino T
Biol Pharm Bull; 2014; 37(6):898-902. PubMed ID: 24882402
[TBL] [Abstract][Full Text] [Related]
10. A case of pseudoaldosteronism induced by glycyrrhizin.
Kageyama Y
Nihon Jinzo Gakkai Shi; 1992 Jan; 34(1):99-102. PubMed ID: 1593803
[TBL] [Abstract][Full Text] [Related]
11. Clinical Risk Factors of Licorice-Induced Pseudoaldosteronism Based on Glycyrrhizin-Metabolite Concentrations: A Narrative Review.
Yoshino T; Shimada S; Homma M; Makino T; Mimura M; Watanabe K
Front Nutr; 2021; 8():719197. PubMed ID: 34604277
[TBL] [Abstract][Full Text] [Related]
12. Hypokalemia and sodium retention in patients with diabetes and chronic hepatitis receiving insulin and glycyrrhizin.
Fujiwara Y; Kikkawa R; Nakata K; Kitamura E; Takama T; Shigeta Y
Endocrinol Jpn; 1983 Apr; 30(2):243-9. PubMed ID: 6357769
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics of five elderly patients with severe hypokalemia induced by glycyrrhizin derivatives].
Yamamoto T; Hatanaka M; Matsuda J; Kadoya H; Takahashi A; Namba T; Takeji M; Yamauchi A
Nihon Jinzo Gakkai Shi; 2010; 52(1):80-5. PubMed ID: 20166546
[TBL] [Abstract][Full Text] [Related]
14. Pseudoaldosteronism due to the concurrent use of two herbal medicines containing glycyrrhizin: interaction of glycyrrhizin with angiotensin-converting enzyme inhibitor.
Iida R; Otsuka Y; Matsumoto K; Kuriyama S; Hosoya T
Clin Exp Nephrol; 2006 Jun; 10(2):131-5. PubMed ID: 16791400
[TBL] [Abstract][Full Text] [Related]
15. A Study of Factors Associated with the Development of Pseudoaldosteronism in Outpatients.
Mantani N; Oka H; Watanabe T
J Altern Complement Med; 2020 Apr; 26(4):329-334. PubMed ID: 31977240
[No Abstract] [Full Text] [Related]
16. The long term efficacy of glycyrrhizin in chronic hepatitis C patients.
Arase Y; Ikeda K; Murashima N; Chayama K; Tsubota A; Koida I; Suzuki Y; Saitoh S; Kobayashi M; Kumada H
Cancer; 1997 Apr; 79(8):1494-500. PubMed ID: 9118029
[TBL] [Abstract][Full Text] [Related]
17. Diospyros rhodocalyx (Tako-Na), a Thai folk medicine, associated with hypokalemia and generalized muscle weakness: a case series.
Othong R; Trakulsrichai S; Wananukul W
Clin Toxicol (Phila); 2017 Nov; 55(9):986-990. PubMed ID: 28617146
[TBL] [Abstract][Full Text] [Related]
18. Potassium chloride mixture may maintain hypokalaemia and hypertension.
Mandoe MJ; Borg R; Hansen D
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567256
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of a hepatic transporter multidrug resistance-associated protein 2 is involved in alteration of pharmacokinetics of glycyrrhizin and its metabolites in a rat model of chronic liver injury.
Makino T; Ohtake N; Watanabe A; Tsuchiya N; Imamura S; Iizuka S; Inoue M; Mizukami H
Drug Metab Dispos; 2008 Jul; 36(7):1438-43. PubMed ID: 18362159
[TBL] [Abstract][Full Text] [Related]
20. 18β-glycyrrhetyl-3-O-sulfate would be a causative agent of licorice-induced pseudoaldosteronism.
Ishiuchi K; Morinaga O; Ohkita T; Tian C; Hirasawa A; Mitamura M; Maki Y; Kondo T; Yasujima T; Yuasa H; Minamizawa K; Namiki T; Makino T
Sci Rep; 2019 Feb; 9(1):1587. PubMed ID: 30733510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
